Accuray Retained Earnings (Accumulated Deficit) 2010-2024 | ARAY
Accuray retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Accuray Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-518 |
| 2023 | $-502 |
| 2022 | $-493 |
| 2021 | $-488 |
| 2020 | $-482 |
| 2019 | $-486 |
| 2018 | $-474 |
| 2017 | $-450 |
| 2016 | $-421 |
| 2015 | $-395 |
| 2014 | $-355 |
| 2013 | $-320 |
| 2012 | $-216 |
| 2011 | $-144 |
| 2010 | $-118 |
| 2009 | $-121 |
| Accuray Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-519 |
| 2024-09-30 | $-522 |
| 2024-06-30 | $-518 |
| 2024-03-31 | $-521 |
| 2023-12-31 | $-515 |
| 2023-09-30 | $-505 |
| 2023-06-30 | $-502 |
| 2023-03-31 | $-500 |
| 2022-12-31 | $-500 |
| 2022-09-30 | $-498 |
| 2022-06-30 | $-493 |
| 2022-03-31 | $-489 |
| 2021-12-31 | $-488 |
| 2021-09-30 | $-488 |
| 2021-06-30 | $-488 |
| 2021-03-31 | $-477 |
| 2020-12-31 | $-477 |
| 2020-09-30 | $-481 |
| 2020-06-30 | $-482 |
| 2020-03-31 | $-482 |
| 2019-12-31 | $-484 |
| 2019-09-30 | $-495 |
| 2019-06-30 | $-486 |
| 2019-03-31 | $-484 |
| 2018-12-31 | $-483 |
| 2018-09-30 | $-478 |
| 2018-06-30 | $-474 |
| 2018-03-31 | $-473 |
| 2017-12-31 | $-464 |
| 2017-09-30 | $-460 |
| 2017-06-30 | $-450 |
| 2017-03-31 | $-445 |
| 2016-12-31 | $-440 |
| 2016-09-30 | $-431 |
| 2016-06-30 | $-421 |
| 2016-03-31 | $-414 |
| 2015-12-31 | $-414 |
| 2015-09-30 | $-408 |
| 2015-06-30 | $-395 |
| 2015-03-31 | $-390 |
| 2014-12-31 | $-387 |
| 2014-09-30 | $-377 |
| 2014-06-30 | $-355 |
| 2014-03-31 | $-345 |
| 2013-12-31 | $-341 |
| 2013-09-30 | $-335 |
| 2013-06-30 | $-320 |
| 2013-03-31 | $-301 |
| 2012-12-31 | $-270 |
| 2012-09-30 | $-241 |
| 2012-06-30 | $-216 |
| 2012-03-31 | $-196 |
| 2011-12-31 | $-181 |
| 2011-09-30 | $-171 |
| 2011-06-30 | $-144 |
| 2011-03-31 | $-119 |
| 2010-12-31 | $-118 |
| 2010-09-30 | $-122 |
| 2010-06-30 | $-118 |
| 2010-03-31 | $-123 |
| 2009-12-31 | $-125 |
| 2009-09-30 | $-124 |
| 2009-06-30 | $-121 |
| 2009-03-31 | $-122 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.164B | $0.447B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.843B | 88.85 |
| Thermo Fisher Scientific (TMO) | United States | $153.281B | 18.54 |
| Edwards Lifesciences (EW) | United States | $45.022B | 29.52 |
| Alcon (ALC) | Switzerland | $43.031B | 29.08 |
| IDEXX Laboratories (IDXX) | United States | $40.969B | 47.08 |
| DexCom (DXCM) | United States | $33.925B | 52.44 |
| IQVIA Holdings (IQV) | United States | $24.535B | 13.74 |
| Mettler-Toledo (MTD) | United States | $23.231B | 27.63 |
| STERIS (STE) | Ireland | $22.352B | 24.65 |
| Waters (WAT) | United States | $20.553B | 29.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.219B | 0.00 |
| Hologic (HOLX) | United States | $12.337B | 13.40 |
| Penumbra (PEN) | United States | $11.191B | 87.83 |
| Sysmex ADR (SSMXY) | Japan | $10.965B | 31.11 |
| Masimo (MASI) | United States | $8.304B | 30.63 |
| Globus Medical (GMED) | United States | $8.001B | 18.76 |
| Teleflex (TFX) | United States | $5.535B | 9.14 |
| Glaukos (GKOS) | United States | $5.232B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.173B | 21.87 |
| TransMedics (TMDX) | United States | $4.139B | 89.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.030B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.375B | 14.14 |
| Veracyte (VCYT) | United States | $2.231B | 31.31 |
| Nihon Kohden (NHNKY) | Japan | $2.050B | 23.51 |
| Elekta AB (EKTAY) | Sweden | $2.021B | 18.17 |
| Alphatec Holdings (ATEC) | United States | $1.862B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.522B | 0.00 |
| Artivion (AORT) | United States | $1.238B | 115.92 |
| Pulse Biosciences (PLSE) | United States | $1.097B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.004B | 5.34 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.799B | 0.00 |
| IRadimed (IRMD) | United States | $0.660B | 33.49 |
| Mesa Laboratories (MLAB) | United States | $0.653B | 14.26 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.562B | 8.74 |
| Beta Bionics (BBNX) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.555B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.539B | 0.00 |
| AxoGen (AXGN) | United States | $0.538B | 0.00 |
| RxSight (RXST) | United States | $0.538B | 0.00 |
| NeuroPace (NPCE) | United States | $0.512B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.467B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.363B | 9.66 |
| ClearPoint Neuro (CLPT) | United States | $0.348B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.283B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.223B | 13.49 |
| Alpha Tau Medical (DRTS) | Israel | $0.199B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.170B | 0.00 |
| LENSAR (LNSR) | United States | $0.167B | 0.00 |
| Inogen (INGN) | United States | $0.158B | 0.00 |
| 908 Devices (MASS) | United States | $0.155B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.148B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.139B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.138B | 0.00 |
| CVRx (CVRX) | United States | $0.138B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.133B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.130B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 12.05 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.91 |